Biovail Corp. is in the Pharma Industry

• Sort by

• Biovail Corporation Files Amended 2006 Annual Report on Form 20-F with the SEC.

  M2 PRESSWIRE-1 June 2007-ExplorationInvestor: Biovail Corporation Files Amended 2006 Annual Report on Form 20-F with the SECC1994-2007 M2 COMMUNICATIONS LTD RDATE:01062007 Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your...

  Research articles 2007-06-01

  Tags: Biovail Corp., FINANCE, SEC, SECURITY

• Biovail to Present at the UBS Leveraged Finance Conference

  TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company will present at the UBS Leveraged Finance Conference 2005 at the Wynn Las Vegas Hotel in Las Vegas, Nevada.

  Research articles 2005-05-10

  Tags: Biovail Corp., finance, UBS AG

• Stocks to Watch: Biovail Corporation, Northwest Airlines.

  M2 PRESSWIRE-6 May 2005-SmallCapReview: Stocks to Watch: Biovail Corporation, Northwest AirlinesC1994-2005 M2 COMMUNICATIONS LTD RDATE:06052005 Biovail Corporation (NYSE: BVF) Announced that it has received an Approval Letter from the United States Food & Drug Administration FDA for Tramadol ODT...

  Research articles 2005-05-06

  Tags: Biovail Corp., FINANCE, Government, HARDWARE, Investment, Northwest Airlines Corp., stock, Tablets

• Top OTC Stocks!

  M2 PRESSWIRE-7 October 2003-Wall Street Capital Funding: Top OTC Stocks!C1994-2003 M2 COMMUNICATIONS LTD RDATE:10072003 Weston, FLA. -- Wall Street News Alert`s "stocks to watch" this morning are: CyberKey Corporation, Inc. (OTC: CYKY), Biovail Corporation (NYSE: BVF), Knight Trading Group Inc (NASDAQ:...

  Research articles 2003-10-07

  Tags: Biovail Corp., FINANCE, Investment, Nasdaq Stock Market Inc., New York Stock Exchange, PCS, stock

• Generic drugmakers post gains. (Markets: Life Sciences).(various briefs)

  GENERIC drugmakers overall have seen healthy profits for the quarter. Three companies, Teva Pharmaceutical Indus-tries Ltd., Mylan Laboratories Inc. and Alpharma Inc., surprised on the upside, while Biovail Corp. and King Pharmaceuticals Inc. fell in line with consensus. However, Ivax Corp. saw earnings fall on pricing...

  Research articles 2002-11-04

  Tags: Banc of America Securities, Biovail Corp., Dr., earnings, FINANCE, IVAX Corp., SALES, Teva

• Biovail appoints new Vice President, Finance and Chief Financial Officer; Mahmood Khan Promoted to Chief Operating Officer

  TORONTO, Canada--BUSINESS WIRE--January 10, 1996--Biovail Corporation International (AMEX, TSE:BVF) today announced the appointment of Robert A. Podruzny as Vice President, Finance and Chief Financial Officer. Mahmood Khan, previous Chief Financial Officer, has been promoted to Chief Operating Officer.

  Research articles 1996-01-10

  Tags: Biovail Corp., finance

Additional Resources

• Biovail Announces U.S. Availability of Xenazine® Tablets

  TORONTO -- Biovail Corporation today announced that Xenazine[R] tablets, an orphan drug recently approved by the U.S. Food and Drug Administration FDA for the treatment of chorea associated with Huntington's disease HD, is now available throughout the United States. Xenazine[R] is the first and only FDA-approved treatment for any HD-related...

  Articles 2008-11-24

• Biovail to Participate at Upcoming Conferences

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will participate at the 2008 Annual Credit Suisse Health Care Conference at the Arizona Biltmore Resort in Phoenix, Arizona and at the Lazard Capital Markets 5th Annual Healthcare Conference at the St. Regis Hotel in New York City. ...

  Articles 2008-11-11

• Biovail Reports Third-Quarter 2008 Financial Results

  Third-Quarter 2008 Revenues of $181.1 Million; Third-Quarter 2008 Net Income of $48.4 Million; U.S. GAAP EPS of $0.31; Acquires First Specialty Central Nervous System Product for Launch in 2008; Files ANDA for Fenofibrate Tablets; Strengthened Management Team with Chief Scientific Officer ...

  Articles 2008-11-06

• Biovail Declares Quarterly Dividend

  Total Dividends Declared Since December 2005 of $4.50 per share TORONTO -- Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company's Board of Directors has declared a quarterly cash dividend of US$0.375 per share payable on January 5, 2009, to shareholders of record at the close of business December...

  Articles 2008-11-06

• Biovail Appoints Dr. H. Christian Fibiger Senior Vice-President, Chief Scientific Officer

  TORONTO -- Biovail Corporation (NYSE, TSX: BVF) today announced the appointment of Dr. H. Christian Fibiger as Senior Vice-President, Chief Scientific Officer of Biovail Laboratories International SRL BLS, the Company's principal operating subsidiary. The appointment is effective November 24, 2008. Dr. Fibiger brings a wealth of academic and...

  Articles 2008-11-06

• Biovail Announces Third-Quarter 2008 Earnings Release, Conference-Call Details

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that it will host a conference call and Webcast on Thursday, November 6, 2008, at 8:30 a.m. EST, for Company executives to discuss third-quarter 2008 financial and operational results. Following the discussion, Biovail executives will address inquiries from investment analysts....

  Articles 2008-10-28

• Generic Wellbutrin to get review

  The Food and Drug Administration says it is ready to conduct a human trial to resolve complaints concerning genetic Wellbutrin XL just months after declaring the Impax Laboratories Inc.-made generic drug to be safe. The brand version is made by Biovail Corp. and sold by GlaxoSmithKline PLC. Over 100 complaints...

  Articles 2008-10-27

• Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Biovail Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the December 8, 2008 Lead Plaintiff Deadline

  Brower Piven, A Professional Corporationannounces that a class action lawsuit has been commenced in the UnitedStates District Court for the Southern District of New York on behalf ofpurchasers of the securities of Biovail Corporation ("Biovail" or the"Company") (NYSE: BVF) during the period between December 14, 2006 and July19, 2007, inclusive...

  Articles 2008-10-15

• Wall Street Media Presents an Exclusive Video from Natixis Bleichroeder 2nd Annual Hidden Gems Conference

  NEW YORK -- Wall Street Media presents an exclusive video of Mr. Joseph J. Corasanti, CEO of CONMED Corporation, (NASDAQ: CNMD) discussing their electro surgery products, and branching out into orthopedics. Please visit the following link to view the video: http://www.wsmco.com/show.aspx?1130_Up_and_Coming_Stocks Wall Street Media...

  Articles 2008-10-13

• INVESTOR ALERT: KGS Notifies Biovail Corporation Purchasers With Losses Greater Than $300,000, of Lead Plaintiff Application Deadline in Securities Class Action Lawsuit -- BVF

  Kahn Gauthier Swick, LLC ("KGS") announcesthat a securities class action lawsuit was filed in the United StatesDistrict Court for the Southern District of New York, on behalf ofpurchasers of the securities and common stock of Biovail Corporation("Biovail") (NYSE: BVF) during the period between December 14, 2006 andJuly 19, 2007, inclusive...

  Articles 2008-10-11

• Biovail Comments on Filing of Lawsuit

  TORONTO -- Biovail Corporation (NYSE, TSX: BVF) today announced that it has been notified that a proposed securities class action lawsuit has been filed in the U.S. District Court Southern District of New York against the Company, its Chairman and two former officers. The complaint has been filed on behalf...

  Articles 2008-10-09

• Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Biovail Corporation

  SAN DIEGO -- Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") (http://www.csgrr.com/cases/biovailcorp/) today announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the Southern District of New York on behalf of purchasers of Biovail Corporation ("Biovail") (NYSE:BVF)...

  Articles 2008-10-09

• Izard Nobel LLP Announces Class Action Lawsuit against Biovail Corporation

  HARTFORD, Conn. -- The law firm of Izard Nobel LLP, which has significant experience representing investors in prosecuting claims of securities fraud, announces that a lawsuit seeking class action status has been filed in the United States District Court for the Southern District of New York on behalf of those...

  Articles 2008-10-09

• Biovail to Present at Natixis Bleichroeder Hidden Gems Conference

  TORONTO -- Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the Company will present at the Natixis Bleichroeder 2nd Annual Hidden Gems Conference at The Waldorf=Astoria hotel in New York City. Biovail's presentation is scheduled for Monday, October 13, 2008 at 2 p.m. EDT. A live and archived Webcast...

  Articles 2008-10-07